Evidence map›Paper›PMID 40157049›Full record

ArticleTransfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis2025

Prevalence of transfusion transmitted infections by mode of donation and remuneration status among blood donors in Georgia, 2018-2023.

Ketevan Shermadini, Evan M Bloch, Shaun Shadaker, Maia Alkhazashvili, Nazibrola Chitadze, Sophia Surguladze, Irinka Tskhomelidze, Vladimer Getia, Ekaterine Adamia, Rania A Tohme and 1 more

Abstract read
In one paragraph

Article in Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ketevan ShermadiniNational Center for Disease Control and Public Health, Tbilisi, Georgia; Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia.
Evan M BlochDepartment of Pathology, Division of Transfusion Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: Ebloch2@jhmi.edu.
Shaun ShadakerDivision of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD and TB Prevention, CDC, Atlanta, GA, USA.
Maia AlkhazashviliNational Center for Disease Control and Public Health, Tbilisi, Georgia.
Nazibrola ChitadzeNational Center for Disease Control and Public Health, Tbilisi, Georgia.
Sophia SurguladzeThe Task Force for Global Health, Tbilisi, Georgia.
Irinka TskhomelidzeThe Task Force for Global Health, Tbilisi, Georgia.
Vladimer GetiaNational Center for Disease Control and Public Health, Tbilisi, Georgia.
Ekaterine AdamiaNational Center for Disease Control and Public Health, Tbilisi, Georgia.
Rania A TohmeDivision of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD and TB Prevention, CDC, Atlanta, GA, USA.
Tamar GabuniaNational Center for Disease Control and Public Health, Tbilisi, Georgia; Ministry for Internally Displaced Persons from the Occupied Territories, Labor, Health and Social Affairs of Georgia, Tbilisi, Georgia.

Funding

The Malaria Transfusion Risk (MATRix) StudyK23HL151826 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI BLOCH, EVAN MARTIN · 2020 to 2024
$882k
Intramural CDC HHS CC999999NHLBI NIH HHS K23 HL151826
6 · The paper itself

Abstract

Global reform of blood transfusion services is underway in the country of Georgia. New legislation mandates exclusive collection of blood from non-remunerated blood donors in Georgia by July 2025. Retrospective data (2018-2023) from the National Blood Donor Registry were analyzed. The prevalence was calculated for human immunodeficiency virus (HIV) antigen/antibody (Ag/Ab), hepatitis C virus antibody (anti-HCV), hepatitis B surface antigen (HBsAg). Results were stratified by remuneration status and mode of donation. Descriptive analysis was performed to elucidate differences in positivity by year and donor type. During 2018-2023, there were a total of 548,530 donations from 221,492 blood donors in Georgia; 68.3 % of donors were male and the median age was 34 years (interquartile range: 2644). Overall, 17.0 % were paid, 24.9 % were replacement, 47.4 % were voluntary non-remunerated blood donors (VNRBD), and 10.7 % had ≥ 2 donations of varying remuneration type. Paid donors had an average of 2.5 donations per year, compared to 1.0 for replacement, and 1.1 for VNRBDs. During 2018-2023, the proportions of paid donors decreased (38.8-22.1 %); the proportions of replacement (19.1-26.0 %) and VNRBDs (38.7-48.3 %) increased. Among first-time donors, prevalence decreased during 2018-2023 for anti-HCV (2.0-0.9 %) but were stable for HBsAg (range: 1.9 %-2.1 %) and anti-HIV (range: 0.1 %-0.2 %). Among repeat donors, prevalence of anti-HCV decreased (from 0.3 % to 0.2 %) while rates were stable for anti-HIV (0.04 %-0.1 %), and HBsAg (0.1 % in all years). The findings underscore the importance of donor retention in concert with efforts to attain exclusive VNRBD.

Indexed as

Blood DonorsBlood TransfusionRemunerationTransfusion ReactionAdultFemaleGeorgia (Republic)Hepatitis BHepatitis CHIV InfectionsHumansMaleMiddle AgedPrevalenceRetrospective StudiesBlood donorsBlood transfusionEpidemiologyGeorgia (Country)Hepatitis C

Identifiers

PMID40157049
PMCPMC12146081

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.